News
Alderley Park-based immunotherapy company Centauri Therapeutics has recieved an additional $5.1m from CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback